Abstract:Key PointsNMDA receptors (NMDARs) are ion channels gated by the excitatory neurotransmitter glutamate. NMDARs are widespread in the CNS and are essential mediators of synaptic transmission and plasticity.NMDARs exist as multiple subtypes that differ in their molecular (subunit) composition. There are assembled as tetramers composed of two obligatory GluN1 subunits along with two GluN2 or GluN3 subunits, of which there are four (GluN2A–GluN2D) and two subtypes (GluN3A and GluN3B) respectively.Each subunit has a typical modular architecture with two large clamshell-like extracellular domains (the N-terminal domain (NTD) involved in assembly and channel modulation and the agonist-binding domain (ABD)), a transmembrane domain (TMD) and a C-terminal domain (CTD) involved in receptor trafficking and signalling. The NTD and CTD regions are the most divergent and account for much of the functional diversity of NMDARs.Each subunit endows the receptor with distinct biophysical, pharmacological and signalling propertiesThe large extracellular region of the receptor harbours an array of binding sites for small-molecule ligands acting as endogenous or exogenous allosteric modulators. Several of these modulators display strong subunit-selectivity, thus allowing for pharmacological profiling of receptor subunit composition.NMDAR subunit composition is plastic, changing during development and according to neuronal activity. Long-term synaptic plasticity of NMDARs also occurs at mature (adult) synapses and has profound consequences on cell firing and subsequent plasticity.Whether specific receptor subtypes carry out specific tasks in the CNS remains a much debated and challenging issue. In particular, evidence points to tri-heteromeric GluN1/GluN2A/GluN2B receptors as critically involved in 'classical' LTP induction at adult CA3–CA1 synapses.NMDARs are implicated in various neurological and psychiatric conditions. Both hypo- and hyperfunction of NMDAR subpopulations can be deleterious, and there is vivid interest in targeting specific subunits for therapeutic interventions.

Allosteric Effect among Sites of the NR2B Subunit of the NMDA Receptor

Distinct structure and gating mechanism in diverse NMDA receptors with GluN2C and GluN2D subunits

Structure, function, and allosteric modulation of NMDA receptors

Bi-directional allosteric pathway in NMDA receptor activation and modulation

Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators

Biochemical studies of the structure and function of the N -methyl- D -aspartate subtype of glutamate receptors

Post-translational modification of NMDA receptor GluN2B subunit and its roles in chronic pain and memory.

Biochemical studies of the structure and function of the<i>N</i>-methyl-<span style="font-variant:small-caps"><small>D</small></span>-aspartate subtype of glutamate receptors

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease

Relationship between availability of NMDA receptor subunits and their expression at the synapse

Mechanism of NMDA Receptor Inhibition and Activation

A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists

Conformational basis of subtype-specific allosteric control of NMDA receptor gating

Subunit Composition of N-methyl-D-aspartate Receptors in the Central Nervous System That Contain the NR2D Subunit.

An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groups

The Effects of NMDA Subunit Composition on Calcium Influx and Spike Timing-Dependent Plasticity in Striatal Medium Spiny Neurons

Subunit Assembly of N-Methyl-d-aspartate Receptors Analyzed by Fluorescence Resonance Energy Transfer

Molecular Level Activation Insights from a NR2A/NR2B Agonist.

Gating mechanism and a modulatory niche of human GluN1-GluN2A NMDA receptors

Extrasynaptic NMDA Receptors Bidirectionally Modulate Intrinsic Excitability of Inhibitory Neurons